Buy Annovis Bio Stock | ANVS Stock Price & Latest News | Public.com
ANVS

Annovis Bio

$0.00 (0.00%)Today
    Small Market Cap
    View Annovis Bio (ANVS) stock trends here

    About ANVS

    Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The firm compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Do...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.31
    -0.46
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.22

    Actual EPS
    Q2 2021

    Stats

    Market Cap$190.7M
    Volume39.82k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$47.99
    1 Year Low$3.83
    Open$26.39
    High$27.22
    Low$25.86

    Buy any stock with any amount of money.

    Download the App
    Download the app